Immunic Statistics
Total Valuation
Immunic has a market cap or net worth of $118.00 million. The enterprise value is $39.26 million.
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Immunic has 90.08 million shares outstanding. The number of shares has increased by 82.57% in one year.
Shares Outstanding | 90.08M |
Shares Change (YoY) | +82.57% |
Shares Change (QoQ) | +4.08% |
Owned by Insiders (%) | 1.16% |
Owned by Institutions (%) | 25.29% |
Float | 52.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.86 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.02.
Current Ratio | 3.75 |
Quick Ratio | 3.58 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -143.47% and return on invested capital (ROIC) is -86.26%.
Return on Equity (ROE) | -143.47% |
Return on Assets (ROA) | -66.80% |
Return on Capital (ROIC) | -86.26% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.24M |
Employee Count | 77 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.59% in the last 52 weeks. The beta is 1.84, so Immunic's price volatility has been higher than the market average.
Beta (5Y) | 1.84 |
52-Week Price Change | +23.59% |
50-Day Moving Average | 1.52 |
200-Day Moving Average | 1.34 |
Relative Strength Index (RSI) | 37.01 |
Average Volume (20 Days) | 1,046,642 |
Short Selling Information
The latest short interest is 3.47 million, so 3.85% of the outstanding shares have been sold short.
Short Interest | 3.47M |
Short Previous Month | 2.68M |
Short % of Shares Out | 3.85% |
Short % of Float | 6.65% |
Short Ratio (days to cover) | 5.76 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -93.65M |
Pretax Income | -95.31M |
Net Income | -95.31M |
EBITDA | -93.53M |
EBIT | -93.65M |
Earnings Per Share (EPS) | -$1.32 |
Full Income Statement Balance Sheet
The company has $79.70 million in cash and $955,000 in debt, giving a net cash position of $78.74 million or $0.87 per share.
Cash & Cash Equivalents | 79.70M |
Total Debt | 955,000 |
Net Cash | 78.74M |
Net Cash Per Share | $0.87 |
Equity (Book Value) | 63.57M |
Book Value Per Share | 0.71 |
Working Capital | 62.30M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$72.34 million and capital expenditures -$420,000, giving a free cash flow of -$72.76 million.
Operating Cash Flow | -72.34M |
Capital Expenditures | -420,000 |
Free Cash Flow | -72.76M |
FCF Per Share | -$0.81 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |